ZEPHYRTEL
2.4.2019 11:51:04 CEST | Business Wire | Press release
ZephyrTel, a division of ESW Capital dedicated to serving global telecommunications operators, is pleased to announce that it has today signed a telecom-focused Strategic Collaboration Agreement with Amazon Web Services (AWS).
This agreement comes less than a year after ZephyrTel’s formation and is testament to the company’s growth strategy and focus on cloud leadership in the Telco market. The strategic collaboration agreement will initially be focused on a joint go-to market approach based on ZephyrTel’s industry leading Customer Experience Management platform, ResponseTek for Telco, which was the first ZephyrTel solution to be migrated to AWS.
Work is already underway to migrate other ZephyrTel solutions to AWS, including Mobilogy, OASIS Cloud Contact Centre, Volt Delta 360 Directory Assistance, PeerApp and Vasona, as well as NewNet Messaging and the Invigorate Rating and Charging platform which ZephyrTel acquired in December 2018.
ZephyrTel’s Dev Factory is also working with AWS in the Artificial Intelligence (AI) and Machine Learning (ML) space and development is underway on the first suite of predictive analytics applications built on AWS.
Mike Shinya, CEO of ZephyrTel, said, “We are dedicated to partnering with our 330 global Telco Operator customers on their journey to becoming Digital Telcos. We expect our cloud offerings to deliver Total Cost of Ownership savings to our customers of up to 90% and we are thrilled to work with AWS’s dedicated Telecom business to extend our joint offerings.”
“Telecommunication service providers are accelerating their migration to AWS in order to deliver lower total cost of IT for their organizations as well as increase automation of their services and business processes in order to drive agility and innovation for their customers,” said Jean-Philippe Poirault, Vice President and Global Head of Telecom, Amazon Web Services EMEA SARL. “We are excited to support ZephyrTel in delivering cloud-deployable telecom solutions on AWS to enable and accelerate the digital transformation journey of our shared customers.”
The agreement will also see ZephyrTel join the AWS Partner Network (APN) with immediate effect. The APN is a global partner program that helps APN Partners build successful AWS-based businesses or solutions by providing business, technical, marketing, and go-to-market support.
About ZephyrTel
Launched in early 2018, ZephyrTel has rapidly scaled up to reach $70M revenues in a short space of time. ZephyrTel has installations in over 50 countries around the world and its customers include more than 330 of the global leading Telecom Operators. The company has access to over 4000 of the world’s top talented engineers and other skilled professionals, available through affiliated company Crossover for Work’s platform. ZephyrTel is currently serving the telecommunications industry worldwide with software products for retail, infrastructure, mobile, cloud, and customer experience and is continuously extending its telco product range. More information is available at www.zephyrtel.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190402005511/en/
Contact:
ZephyrTel For further information please email: Mike Shinya, CEO mike.shinya@zephyrtel.com Ali Perkins, Chief Marketing Officer ali.perkins@zephyrtel.com
For media enquiries please email: Paula Elliott, Managing Director, C8 Consulting paula@c8consulting.co.uk
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pacific Defense Awarded U.S. Marine Corps Contract for Next Generation Electronic Warfare Prototype29.4.2026 13:00:00 CEST | Press release
Award advances SOSA/CMOSS mission system ecosystem and informs future EW fielding decisions Pacific Defense has been awarded a 12-month rapid prototyping contract by the U.S. Marine Corps Systems Command (MARCORSYSCOM), Program Manager for Tactical Communications and Electronic Warfare (PM TCE) to support next-generation electronic warfare (EW) capability evaluation. The effort will assess Modular Open Systems Approach (MOSA) Electronic Warfare (EW) mission systems and their potential in modernizing USMC capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429918712/en/ Pacific Defense's Next Generation Electronic Warfare System enables rapid integration of new hardware and software into a common chassis, accelerating capability insertion while reducing vendor lock and lifecycle costs. Under the contract, Pacific Defense will deliver SOSA/CMOSS-aligned mission systems to enable vehicle-based experimentation by U.S
Visa Accelerates Stablecoin Momentum: Adding Five Blockchains for Settlement29.4.2026 13:00:00 CEST | Press release
Stablecoin settlement pilot sees record growth 50% quarter over quarter, reaching $7B run rate. Today, Visa (NYSE: V) announced that it is adding five blockchains to its global stablecoin settlement pilot, expanding how issuers and acquirers can settle with the network. As stablecoins move into mainstream payment flows, Visa’s stablecoin settlement pilot now supports nine blockchains and has reached a $7 billion annualized stablecoin settlement run rate, up 50% since last quarter. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429143049/en/ Visa is adding support for five additional blockchains, further expanding its multi-chain settlement capabilities. “Our partners are building in a multi-chain world, and they expect their options to reflect that reality,” said Rubail Birwadker, Global Head of Growth Products and Strategic Partnerships, Visa. “Expanding our stablecoin settlement pilot program to more blockchains means o
U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA29.4.2026 12:00:00 CEST | Press release
TEVIMBRA plus ZIIHERA and chemotherapy regimen delivered statistically significant median OS of 26.4 months, an unprecedented result in this challenging diseaseResults from the global Phase 3 HERIZON-GEA-01 study demonstrate potential to change clinical practice in advanced HER2+ gastroesophageal adenocarcinoma BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to a supplemental Biologics License Application (sBLA) for TEVIMBRA® (tislelizumab) in combination with ZIIHERA® (zanidatamab) and chemotherapy for the first-line treatment of unresectable locally advanced/metastatic HER2-positive (HER2) gastric, gastroesophageal junction, or esophageal adenocarcinoma. The FDA has also granted Breakthrough Therapy Designation to the regimen of ZIIHERA in combination with fluoropyrimidine- and platinum-containing chemotherapy, with and without TEVIMBRA, in this indica
European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe29.4.2026 11:30:00 CEST | Press release
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for intravenous use, the first and only approved biosimilar to PERJETA (pertuzumab) in Europe, for all indications of the reference product.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429686426/en/ “As the first, and currently the only, pertuzumab biosimilar in Europe, the EC’s approval of POHERDY marks an important milestone in expanding access to treatments for patients with certain HER2-positive breast cancers, particularly as breast cancer is the most commonly diagnosed cancer among women in the European Union,” said Joe Azzinaro, Vice President, Global Commercial Lead Biosimilars, at Organon.2,3 “Organon’s growing global portfolio of biosimilars reinforces our ongoing commitment to supporting the sustainability of healt
Andreas Goppelt Appointed Managing Director of OrphaCare29.4.2026 10:27:00 CEST | Press release
OrphaCare, a global specialist for the development and marketing of medical devices for drug delivery and part of the AOP Health Group, has appointed Andreas Goppelt as its new Managing Director, succeeding Georg Fischer. In this role, the seasoned medical device expert will focus on broadening the company’s strategic scope and driving its next phase of growth. OrphaCare plays a key role in supporting AOP Health’s integrated therapies approach, and the Group’s long-term expansion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429303533/en/ Portrait Andreas Goppelt, Managing Director OrphaCare (copyright: AOP Health/Studio Koekart) Andreas Goppelt brings more than 25 years of leadership experience across MedTech, biotechnology and the pharmaceutical industry. He has a proven track record of driving innovation, scaling global organizations, and delivering growth in highly regulated healthcare environments. In his new role,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom